These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8891026)

  • 41. Oral pentoxifylline and topical clobetasol propionate ointment in the treatment of pretibial myxoedema, with concomitant improvement of Graves' ophthalmopathy.
    Pineda AM; Tianco EA; Tan JB; Casintahan FA; Beloso MB
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1441-3. PubMed ID: 17958873
    [No Abstract]   [Full Text] [Related]  

  • 42. [Effective treatment of chronic inflammatory skin diseases. Once a week occlusion therapy with clobetasol propionate and Duoderm].
    Volden G
    Tidsskr Nor Laegeforen; 1992 Apr; 112(10):1272-4. PubMed ID: 1579907
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Urgotul: alternative to conventional non-adherence dressings.
    Benbow M
    Br J Nurs; 2002 Jan 24-Feb 13; 11(2):135-8. PubMed ID: 11823742
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Emovate in pediatric practice. A Swiss study on a new local corticosteroid].
    Graber W; Miescher A; Schneider HJ
    Ther Umsch; 1983 May; 40(5):449-53. PubMed ID: 6346567
    [No Abstract]   [Full Text] [Related]  

  • 45. Topical treatment of necrotic foot ulcers in diabetic patients: a comparative trial of DuoDerm and MeZinc.
    Apelqvist J; Larsson J; Stenström A
    Br J Dermatol; 1990 Dec; 123(6):787-92. PubMed ID: 2265095
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative toxicity study of hydrocortisone 17-butyrate 21-propionate (HBP) ointment and other topical corticosteroids in rats.
    Kimura M; Tarumoto Y; Nakane S; Otomo S
    Drugs Exp Clin Res; 1986; 12(8):643-52. PubMed ID: 3757761
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Topical 0.05% clobetasol propionate versus 1% pimecrolimus ointment in vitiligo.
    Coskun B; Saral Y; Turgut D
    Eur J Dermatol; 2005; 15(2):88-91. PubMed ID: 15757818
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clobetasol propionate 0.05% under occlusion in the treatment of alopecia totalis/universalis.
    Tosti A; Piraccini BM; Pazzaglia M; Vincenzi C
    J Am Acad Dermatol; 2003 Jul; 49(1):96-8. PubMed ID: 12833016
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Equal efficacy of topical tacrolimus and clobetasone butyrate in pemphigus foliaceus.
    Cohen SN; Lim RP; Paul CJ; Abdullah A
    Int J Dermatol; 2006 Nov; 45(11):1379. PubMed ID: 17076736
    [No Abstract]   [Full Text] [Related]  

  • 50. Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005% betamethasone dipropionate 0.064% ointment for the treatment of moderate to severe plaque psoriasis.
    Menter A; Abramovits W; Colón LE; Johnson LA; Gottschalk RW
    J Drugs Dermatol; 2009 Jan; 8(1):52-7. PubMed ID: 19180896
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clobetasol propionate followed by calcipotriol is superior to calcipotriol alone in topical treatment of psoriasis.
    Austad J; Bjerke JR; Gjertsen BT; Helland S; Livden JK; Morken T; Mørk NJ
    J Eur Acad Dermatol Venereol; 1998 Jul; 11(1):19-24. PubMed ID: 9731961
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cushing's syndrome and adrenal suppression from percutaneous absorption of clobetasol propionate in infants.
    Cherian MP; AbdulJabbar M
    Saudi Med J; 2001 Dec; 22(12):1139-41. PubMed ID: 11802195
    [No Abstract]   [Full Text] [Related]  

  • 53. Clobetasol propionate for psoriasis: are ointments really more potent?
    Warino L; Balkrishnan R; Feldman SR
    J Drugs Dermatol; 2006 Jun; 5(6):527-32. PubMed ID: 16774104
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Occlusive dressing or active product?].
    Fairbrother JE
    Soins Chir; 1989 May; (99):42-4. PubMed ID: 2749085
    [No Abstract]   [Full Text] [Related]  

  • 55. The efficacy of '0.05% Clobetasol + 2.5% zinc sulphate' cream vs. '0.05% Clobetasol alone' cream in the treatment of the chronic hand eczema: a double-blind study.
    Faghihi G; Iraji F; Shahingohar A; Saidat A
    J Eur Acad Dermatol Venereol; 2008 May; 22(5):531-6. PubMed ID: 18284511
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of perniosis with oral pentoxyfylline in comparison with oral prednisolone plus topical clobetasol ointment in Iraqi patients.
    Noaimi AA; Fadheel BM
    Saudi Med J; 2008 Dec; 29(12):1762-4. PubMed ID: 19082229
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Peristomal dermatoses: a novel indication for topical steroid lotions.
    Lyon CC; Smith AJ; Griffiths CE; Beck MH
    J Am Acad Dermatol; 2000 Oct; 43(4):679-82. PubMed ID: 11004626
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Occlusive versus nonocclusive calcipotriol ointment treatment for palmoplantar psoriasis.
    Duweb GA; Abuzariba O; Rahim M; al-Taweel M; al-Alem S; Abdulla SA
    Int J Tissue React; 2001; 23(2):59-62. PubMed ID: 11447774
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Topical clobetasol propionate 0.05% cream alone and in combination with azathioprine in patients with chronic hand eczema: an observer blinded randomized comparative trial.
    Agarwal US; Besarwal RK
    Indian J Dermatol Venereol Leprol; 2013; 79(1):101-3. PubMed ID: 23254739
    [No Abstract]   [Full Text] [Related]  

  • 60. Using transparent polyurethane film and hydrocolloid dressings to prevent pressure ulcers.
    Dutra RA; Salomé GM; Alves JR; Pereira VO; Miranda FD; Vallim VB; de Brito MJ; Ferreira LM
    J Wound Care; 2015 Jun; 24(6):268, 270-1, 273-5. PubMed ID: 26075375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.